PCS
GMAB icon

Personal CFO Solutions’s Genmab GMAB Stock Holding History

Personal CFO Solutions’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,866
Closed -$292K – 548
2026
Q1 		$292K Buy
10,866
+386
+4% +$11.6K 0.04% 390
2025
Q4 		$323K Buy
+10,480
New +$327K 0.05% 343
2023
Q1 		– Sell
-5,584
Closed -$237K – 489
2022
Q4 		$237K Sell
5,584
-916
-14% -$37.7K 0.05% 368
2022
Q3 		$209K Buy
+6,500
New +$228K 0.05% 360
2022
Q1 		– Sell
-6,053
Closed -$239K – 487
2021
Q4 		$239K Sell
6,053
-387
-6% -$16.1K 0.04% 397
2021
Q3 		$281K Buy
+6,440
New +$289K 0.06% 305

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Personal CFO Solutions's GMAB Position: Q2 2026 in Review

Personal CFO Solutions sold out of Genmab (GMAB) in Q2 2026, closing a stake of 10,866 shares — an estimated $292K sold.

Personal CFO Solutions first reported a position in GMAB in Q3 2021 and held it in 6 quarters. The position peaked at $323K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Personal CFO Solutions reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Personal CFO Solutions sold 10,866 Genmab shares in Q2 2026, an estimated $292K.
  • Personal CFO Solutions first reported a position in Genmab in Q3 2021 and held it in 6 quarters.
  • Personal CFO Solutions's Genmab position peaked at $323K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Personal CFO Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.